We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Penicillin Allergy Increases Surgical Site Infection Risk

By HospiMedica International staff writers
Posted on 16 Oct 2017
Researchers at Massachusetts General Hospital (MGH; Boston, USA), Harvard Medical School (HMS; Boston, MA, USA), and other institutions conducted a retrospective cohort study involving 8, 385 hip arthroplasty, knee arthroplasty, hysterectomy, colon surgery, and coronary artery bypass grafting (CABG) patients treated between 2010 and 2014 in order to compare SSI susceptibility, both with and without a reported penicillin allergy. More...
The primary outcome was SSI, with a secondary outcome of perioperative antibiotic use.

Of the study patients, 11% reported a penicillin allergy, and 2.7% suffered an SSI; analysis revealed that the patients reporting a penicillin allergy had a 51% increased odds of SSI. Patients reporting penicillin allergy were administered less cefazolin and more clindamycin, vancomycin, and gentamicin compared with those without a reported penicillin allergy. According to the researchers, the increased SSI risk was entirely mediated by the patients’ receipt of an alternative perioperative antibiotic, and practically all of them could have safely received standard testing for penicillin allergies. The study was presented at the annual IDWeek meeting, held during October 2017 in San Diego (CA, USA).

“We hope our findings spark reconsideration of the language about penicillin allergy testing in the national guidelines,” concluded senior author Erica Shenoy, MD, of HMS. “In the meantime, I would recommend that any patients with a history of allergy to penicillin or to cephalosporins who are scheduled for surgery to ask their doctor whether an antibiotic would be needed and, if so, discuss a referral for an allergy evaluation in advance to increase their chances of getting the most effective antibiotic.”

Penicillin, discovered in 1928 by Scottish scientist Alexander Fleming, is a β-lactam antibiotic effective against many bacterial infections caused by staphylococci and streptococci. Penicillin side effects such as nausea and vomiting, mild diarrhea, or headache commonly occur while taking the drug, but do not necessarily herald an allergic reaction. Mistaking side effects for allergic reaction leads to penicillin allergies being incorrectly reported by patients about 90% of the time.

Related Links:
Massachusetts General Hospital
Harvard Medical School


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.